Abstract: An electrochemical cell comprising a lithium anode, a cathode comprising a blank cut from a free-standing sheet of a silver vanadium oxide mixture contacted to a current collector. The active material has having a relatively lower surface area and an electrolyte activating the anode and the cathode is described. By optimizing the cathode active material surface area in a SVO-containing cell, the magnitude of the passivating film growth at the solid-electrolyte interphase (SEI) and its relative impermeability to lithium ion diffusion is reduced. Therefore, by using a cathode of an active material in a range of from about 0.2 m2/gram to about 2.6 m2/gram, and preferably from about 1.6 m2/gram to about 2.4 m2/gram, it is possible to eliminate or significantly reduce undesirable irreversible Rdc growth and voltage delay in the cell and to extend its useful life in an implantable medical device.

Abstract: A torque limiting mechanism used for securing fasteners is described. The torque limiting mechanism consists of a shaft, a torque gear having a plurality of ball bearings, a threshold bearing and a variable force applying subassembly. The torque limiting mechanism further consisting of a lock bushing and retaining ring placed circumferentially around the proximal end of the shaft. The lock bushing and retaining ring reduce structural misalignments and increase the accuracy of the device.

Abstract: A medical lead system includes at least one bandstop filter for attenuating current flow through the lead across a range of frequencies. The bandstop filter has an overall circuit Q wherein the resultant 3 dB bandwidth is at least 10 kHz. The values of capacitance and inductance of the bandstop filter are selected such that the bandstop filter is resonant at a selected center frequency or range of frequencies. Preferably, the bandstop filter has an overall circuit Q wherein the resultant 10 dB bandwidth is at least 10 kHz. Such bandstop filters are backwards compatible with known implantable deployment systems and extraction systems.

Abstract: A method for making a deflectable catheter includes positioning a flexible element along a catheter liner. A flexible element distal portion extends along at least a portion of a deflectable distal end portion of the catheter liner. At least one anchor is engaged to the flexible element distal portion. The flexible element resides radially between the catheter liner and a band extending at least part way around a perimeter of the liner. An encapsulant, positioned around at least the flexible element distal portion, forms at least a portion of a sidewall of the deflectable distal end portion of the liner. The anchor and band are within the sidewall so that the encapsulant transmits pushing and pulling forces from the at least one anchor to the deflectable distal end portion of the liner.

Abstract: A bandstop filter includes a capacitance in parallel with an inductance and is placed in series with the implantable lead of an active implantable medical device, wherein values of capacitance and inductance are selected such that the bandstop filter attenuates RF current flow at a selected center MRI RF pulsed frequency or across a range of frequencies. The Qi of the inductor and the Qc of the capacitor are controlled to reduce the overall Q of the bandstop filter to attenuate current flow through the implantable lead along a range of selected frequencies. In a preferred form, the bandstop filter is integrated into a Tip and/or Ring electrode for the active implantable medical device.

Abstract: A bandstop filter includes a capacitance in parallel with an inductance and is placed in series with the implantable lead of an active implantable medical device, wherein values of capacitance and inductance are selected such that the bandstop filter attenuates RF current flow at a selected center MRI RF pulsed frequency or across a range of frequencies. The Qi of the inductor and the Qc of the capacitor are controlled to reduce the overall Q of the bandstop filter to attenuate current flow through the implantable lead along a range of selected frequencies. In a preferred form, the bandstop filter is integrated into a Tip and/or Ring electrode for the active implantable medical device.

Abstract: A TANK filter is provided for a lead wire of an active medical device (AMD). The TANK filter includes a capacitor in parallel with an inductor. The parallel capacitor and inductor are placed in series with the lead wire of the AMD, wherein values of capacitance and inductance are selected such that the TANK filter is resonant at a selected frequency. The Q of the inductor may be relatively maximized and the Q of the capacitor may be relatively minimized to reduce the overall Q of the TANK filter to attenuate current flow through the lead wire along a range of selected frequencies. In a preferred form, the TANK filter is integrated into a TIP and/or RING electrode for an active implantable medical device.

Abstract: A system is provided for identifying implanted medical devices, leads and systems, as well as objects in close proximity to a patient having an implanted active medical device, using a radio frequency identification (RFID) tag having retrievable information relating to the AIMD, lead system and/or patient. An RFID tag communicator includes a circuit for limiting the total continuous transmit time of an interrogation signal, and a time-out circuit for delaying a second and any subsequent interrogation of the RFID tag.

Abstract: One or more inductors and one or more capacitors are physically disposed relative to one another in series and are electrically connected to one another in parallel to form a bandstop filter. Chip inductors and chip capacitors having spaced apart conductive terminals are physically arranged in end-to-end abutting relation to minimize electrical potential between adjacent conductive terminals. The bandstop filter may be hermetically sealed within a biocompatible container for use with an implantable lead or electrode of a medical device. The values of the inductors and the capacitors are selected such that the bandstop filter is resonant at one or more selected frequencies, such as an MRI pulsed frequency.

Abstract: An introducer assembly includes a sheath and a dilator. A biodegradable shroud covers the distal portion of the introducer assembly on the surface of both the sheath and the dilator. The biodegradable shroud dissolves in blood after being exposed for a predetermined time. Afterwards, the dilator can be separated from the sheath without breaking the sheath. The shroud improves movement of the introducer assembly through a venous system by preventing body tissue from getting caught in the space between the dilator and the shroud, for example should a “fish mouth” separation occur between them.

Abstract: A multilayer helical wave filter having a primary resonance at a selected RF diagnostic or therapeutic frequency or frequency range, includes an elongated conductor forming at least a portion of an implantable medical lead. The elongated conductor includes a first helically wound segment having at least one planar surface, a first end and a second end, which forms a first inductive component, and a second helically wound segment having at least one planar surface, a first end and a second end, which forms a second inductive element. The first and second helically wound segments are wound in the same longitudinal direction and share a common longitudinal axis. Planar surfaces of the helically wound segments face one another, and a dielectric material is disposed between the facing planar surfaces of the helically wound segments and between adjacent coils of the helically wound segments, thereby forming a capacitance.

Abstract: Drug delivery methods and systems that include a determination of whether a cardiac condition is normal or abnormal, so that a drug may be administered in accordance with that determination. In one implementation, a drug delivery device may be controlled to reduce or stop the drug administration when a normal cardiac condition is detected. In another implementation, a patient monitoring device determines the duration that a cardiac condition is normal and provides an output indicative of the determination so that the patient may alter a therapy accordingly.

Abstract: One or more inductors and one or more capacitors are physically disposed relative to one another in series and are electrically connected to one another in parallel to form a bandstop filter. Chip inductors and chip capacitors having spaced apart conductive terminals are physically arranged in end-to-end abutting relation to minimize electrical potential between adjacent conductive terminals. The bandstop filter may be hermetically sealed within a biocompatible container for use with an implantable lead or electrode of a medical device. The values of the inductors and the capacitors are selected such that the bandstop filter is resonant at one or more selected frequencies, such as an MRI pulsed frequency.

Abstract: An introducer assembly includes a sheath having a sheath proximal end and distal end, and a passage therethrough. The introducer assembly further includes a handle assembly that is mechanically and/or bonded coupled with a tubular sheath.

Abstract: A method for providing a header assembly for connecting an implantable medical device to at least one conductor lead terminating within a patient intended to be assisted by the medical device is provided. The implantable medical device is comprised of at least one feedthrough wire extending from the control circuitry and through a wall of the housing. The header assembly is comprised of an insulative body that is mountable on the housing of the medical device. The insulative body supports at least one conductor subassembly comprising a terminal that is directly connectable to the conductor lead, an intermediate conductor comprising a distal end connected to the terminal and a proximal end connected to a connector. Methods for making the header assembly and for connecting the header assembly to the implantable medical device are also disclosed.

Abstract: A tunneling tool for creating a pathway for implanting a therapy delivery element in a living body. The tunneling tool includes a malleable elongated shaft having a distal end. A sheath having a lumen is slidably positioned over a portion of the shaft. A primary handle secured to proximal end of the shaft permits a user to advance and manipulate the shaft and the sheath in the living body. A secondary handle with an opening is slidably positioned on the shaft between the primary handle and the sheath. The opening has a diameter less than an outside diameter of a proximal end of the sheath. A locking mechanism releasably engages the secondary handle to the primary handle. The sheath is retained in a desired location within the living body by securing the secondary handle relative to the living body as the primary handle is used to remove the shaft from the sheath.

Abstract: An EMI shielded conduit assembly for an active implantable medical device (AIMD) includes an EMI shielded housing for the AIMD, a hermetic feedthrough terminal associated with the AIMD housing, and an electronic circuit board, substrate or network disposed within the AIMD housing remote from the hermetic feedthrough terminal. At least one leadwire extends from the hermetic feedthrough terminal to the remote circuit board, substrate or network. An EMI shield is conductively coupled to the AIMD housing and substantially co-extends about the leadwire in non-conductive relation thereto.

Abstract: An RFID tag is disposed within a hermetically sealed housing of an IMD. Low frequency RFID interrogators and tags are used, and the housing walls are made of materials, and/or are reduced in thickness, to facilitate RF communication between the RFID tag and an RFID reader/interrogator programmer. An RFID reader/interrogator may be used which has a limited transmit time and time-out period to avoid interference with the operation of the IMD.